Cumberland Pharmaceuticals (CPIX) Non-Current Debt (2010 - 2026)

Cumberland Pharmaceuticals (CPIX) has 16 years of Non-Current Debt data on file, last reported at $5.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Debt changed 0.0% year-over-year to $5.2 million; the trailing twelve-month figure through Mar 2026 stood at $5.2 million (changed 0.0% YoY), and the FY2025 full-year result was $5.2 million, down 48.5% from the prior year.
• Non-Current Debt steadied at $5.2 million in Q1 2026, from $5.2 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $20.0 million in Q1 2022 to a low of $5.2 million in Q1 2025.
• A 5-year average of $12.1 million and a median of $12.9 million in 2023 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt surged 35.71% in 2022 and sank 67.43% in 2025, its largest moves.
• Tracing CPIX's Non-Current Debt over 5 years: stood at $16.2 million in 2022, then slipped by 21.09% to $12.8 million in 2023, then decreased by 20.4% to $10.2 million in 2024, then plunged by 48.5% to $5.2 million in 2025, then changed by 0.0% to $5.2 million in 2026.
• Business Quant data shows CPIX's Non-Current Debt at $5.2 million in Q1 2026, $5.2 million in Q4 2025, and $5.2 million in Q3 2025.